Dr Reddys Laboratories is currently trading at Rs. 1667.50, up by 32.25 points or 1.97% from its previous closing of Rs. 1635.25 on the BSE.
The scrip opened at Rs. 1651.00 and has touched a high and low of Rs. 1688.80 and Rs. 1636.00 respectively. So far 154634 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 5 has touched a 52 week high of Rs. 1716.00 on 02-May-2011 and a 52 week low of Rs. 1387.00 on 22-Aug-2011.
Last one week high and low of the scrip stood at Rs. 1700.00 and Rs. 1603.00 respectively. The current market cap of the company is Rs. 27958.66 crore.
The promoters holding in the company stood at 25.61% while Institutions and Non-Institutions held 40.92% and 16.02% respectively.
Dr Reddys Laboratories has reported results for third quarter ended December 31, 2011.
The company has posted a fall of 58.89% in its net profit of Rs 108.03 crore for the quarter ended December 31, 2011 as compared to Rs 262.77 crore for the same quarter in the previous year. However, total income has increased by 14.36% from Rs 1426.97 crore for Q3FY11 to Rs 1631.86 crore in the quarter under review.
On the consolidated basis, the group has posted 87.80% surge in its net profit to Rs 512.96 crore for the quarter ended December 31, 2011 as compared to Rs 273.14 crore in the same quarter last year. Total income of the company improved by 46.52% to Rs 2752.71 crore for the quarter compared to Rs 1878.72 crore in the quarter, year ago.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1791.25 |
Dr. Reddys Lab | 1218.10 |
Cipla | 1493.05 |
Lupin | 2066.35 |
Zydus Lifesciences | 950.00 |
View more.. |